A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer

[21] Ouchi N(2003)Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece J Clin Endocrinol Metab 88 993-997

[22] Weyer C(2004)Circulating adiponectin and endometrial cancer risk J Clin Endocrinol Metab 89 1160-1163

[23] Funahashi T(2006)Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 2376-2381

[24] Tanaka S(2007)High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease Am J Cardiol 100 569-574

[25] Fruebis J(2007)Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men Clin Endocrinol (Oxf) 67 276-281

[26] Tsao TS(2004)Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 27-31

[27] Javorschi S(2005)Peroxisome proliferator-activated receptor (PPAR) α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ and their combination Diabetes 54 3358-3370

[28] Yamauchi T(2006)Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 1357-1362

[29] Kamon J(2004)Adiponectin differentially regulates cytokines in porcine macrophages Biochem Biophys Res Commun 316 924-929

[30] Waki H(2000)Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 1723-1732

[21] Ouchi N(2003)Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece J Clin Endocrinol Metab 88 993-997

[22] Weyer C(2004)Circulating adiponectin and endometrial cancer risk J Clin Endocrinol Metab 89 1160-1163

[23] Funahashi T(2006)Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 2376-2381

[24] Tanaka S(2007)High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease Am J Cardiol 100 569-574

[25] Fruebis J(2007)Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men Clin Endocrinol (Oxf) 67 276-281

[26] Tsao TS(2004)Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 27-31

[27] Javorschi S(2005)Peroxisome proliferator-activated receptor (PPAR) α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ and their combination Diabetes 54 3358-3370

[28] Yamauchi T(2006)Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 1357-1362

[29] Kamon J(2004)Adiponectin differentially regulates cytokines in porcine macrophages Biochem Biophys Res Commun 316 924-929

[30] Waki H(2000)Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 1723-1732